We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Spinal Fusion Has Not Lowered Risk of Repeat Back Surgery

By HospiMedica staff writers
Posted on 10 Oct 2007
Despite increased rates of spinal fusion surgery, the percentage of patients requiring further low back surgery after spinal fusion has actually increased since the early 1990s, according to a new study.

Researchers of the Center for Cost and Outcomes Research at the University of Washington (Seattle, USA) analyzed rates of spinal fusion and repeated low back surgery during two periods: 1990-93 and 1997-2000. More...
The analysis included about 2,500 patients undergoing some type of surgery on the lumbar spine during each period. During the 1990s, the percentage of patients undergoing spinal fusion more than doubled, from about 9% during 1990-93 to 19% during 1997-2000.

However, the researchers found, as the rate of spinal fusion surgery increased, so did the proportion of patients who later required another lower-back operation. Of patients undergoing spinal fusion during 1990-93, about 12% had another lumbar spine operation within four years. For patients undergoing spinal fusion during 1997-2000, this figure increased to 14%. After adjustment for other factors, the risk of repeated low-back surgery after spinal fusion increased by about 16% from the beginning to the end of the decade. Among patients undergoing spinal fusion in 1997-2000, the risk of repeated lower back surgery within the first year was about 40% higher than for patients initially operated on in the early 1990s. After the first year, repeat operation rates were similar between the two periods. The study was published in the September 1, 2007, issue of Spine.

"Repeat lumbar spine operations are generally undesirable, implying persistent symptoms, progression of degenerative changes, or treatment complications,” concluded lead author Brook I. Martin, M.P.H., and colleagues. "A higher proportion of fusion procedures and the introduction of new spinal implants between 1993 and 1997 did not reduce reoperation rates.”

The researchers also highlighted the need for efforts to better identify patients most likely to benefit from spinal fusion surgery, as well as to demonstrate the safety and effectiveness of new surgical devices and techniques.


Related Links:
University of Washington

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.